[ET Net News Agency, 10 February 2026] HANSOH PHARMA (03692) rose 3% to HK$38.24.
It hits an intra-day high of HK$38.24, breaking above the 100-D SMA of HK$38.172, and an intra-day low of HK$37.42. The total shares traded was 2.58 million, with a value of HK$97.41m. The active buy/sell ratio is 68:32, with net buying turnover of HK$31.82m. MERRILL LYNCH FE accounts for greatest net responsive buying turnover of HK$6.77m, with volume weighted average price of HK$37.764. BARCLAYS CAPITAL ASIA accounts for greatest net responsive selling turnover of HK$6.84m, with volume weighted average price of HK$37.768. The stock has risen a combined 4.8% over the past 2 consecutive trading days.
The Hang Seng Index now rose 295 points, or 1.1% to 27,322.
Basic Information| Nominal | 38.240 | % Chg | +3.02% |
| High | 38.240 | Low | 37.420 |
| Shares Tr | 2.58m | Turnover | 97.41m |
| 10-D SMA | 37.634 | %H.V | 31.695 |
| 20-D SMA | 39.324 | VWAP | 37.738 |
| 50-D SMA | 39.597 | RSI14 | 46.897 |
Status: Breaking above the 100-D SMA, active buy/sell ratio is 68:32, with net buying turnover of HK$31.82m, rising a combined 4.8% over the past 2 consecutive trading days
Performance of stocks in the same sector or of relevance| Stock (Code) | Price (HK$) | Change (%) |
|---|
| HANSOH PHARMA (03692) | 38.24 | +3.02 |
| SIHUAN PHARM (00460) | 1.68 | -1.18 |
| GRAND PHARMA (00512) | 7.93 | +0.25 |
| SINO BIOPHARM (01177) | 6.85 | +3.79 |
| HENGRUI PHARMA (01276) | 69.85 | +1.16 |
| LIVZON PHARMA (01513) | 29.88 | +0.54 |
| LUYE PHARMA (02186) | 2.80 | +1.08 |
| FOSUN PHARMA (02196) | 21.46 | +3.37 |
| SH PHARMA (02607) | 11.84 | +0.42 |
| CHINARES PHARMA (03320) | 4.68 | Unchanged |
(ed)
